Judgment_paragraph 13 · LFB Biomédicaments SA and Others v Ministre des Finances et des Comptes publics and Ministre des Affaires sociales et de la Santé (C-271/14, C-273/14)

13In those circumstances, the Conseil d’État decided to stay the proceedings and to refer the following questions to the Court of Justice for a preliminary ruling:‘In Case C-271/14:Does Article 6(5) of [Directive 89/105] require that a statement of reasons be given for a decision to remove a proprietary medicinal product from the list of medicinal products provided to inpatients in health establishments which may be covered by compulsory health insurance schemes in addition to services relating to hospital treatment covered by fixed payments in respect of periods of hospitalisation and hospital care determined in accordance with diagnosis-related groups?In Case C-273/14:Does [Article 6(3) and (5) of Directive 89/105] apply to decisions to remove a proprietary medicinal product from the list of medicinal products provided to inpatients in health establishments which may be covered by compulsory health insurance schemes in addition to services relating to hospital treatment covered by fixed payments in respect of periods of hospitalisation and hospital care determined in accordance with diagnosis-related groups?’